Frontlight ResearchEarly access
CompletedNo phase
Platelet-Rich Plasma Composition and Clinical Effects in Knee Osteoarthritis
Key facts
- Who runs it
- Iuliu Hatieganu University of Medicine and Pharmacy
- Where
- Romania1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 15 Oct 2025
- Ended
- 20 Dec 2025
- Type of study
- Interventional
- Treatments tested
- intra-articular administration of plasma rich in platelets (PRP)
- Record updated
- 30 April 2026
Who can take part
- Age
- 40 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Age between 40 and 80 years
- Diagnosis of unilateral or bilateral gonarthrosis radiological grade 2-3 Kellgren-Lawrence
- Knee joint pain greater than 4 on the VAS scale
- History of knee joint pain for at least 6 months
- Patients who are to receive an inpatient PRP injection
Who cannot take part
- History of inflammatory rheumatological disease or gout
- History of recent minor (1 month) or major (2 years) trauma to the knee joint
- History of knee surgery or arthroscopy
- Diagnosis of neoplasia, hematological or immunological diseases
- Clinical or biological signs of acute infection
- Coagulation disorders
- Diagnosis of secondary gonarthrosis
- Infiltrations, physiotherapy or other knee treatments in the last 3 months
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, observational cohort study involving 40 patients with primary knee osteoarthritis hospitalized in a rehabilitation hospital in Cluj-Napoca. All participants will receive intra-articular platelet-rich plasma (PRP) injections. The study aims to analyze PRP composition and inflammatory biomarkers to better understand disease mechanisms and evaluate treatment effectiveness.
The group in the trial
- 40 patients with knee arthrosis receiving an infiltration with plasma rich in plateletsOther group
intra-articular administration of plasma rich in platelets (PRP)
Treatment: intra-articular administration of plasma rich in platelets (PRP)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of the Composition of Platelet-rich Plasma and Its Clinical and Molecular Effect in the Biological Treatment of Knee Arthrosis
- Record updated
- 30 April 2026